Non-invasive brain stimulation for migraine pain
Part of Brain & nervous system clinical trials.
This trial tests a non-invasive treatment called repetitive transcranial magnetic stimulation (rTMS) that uses magnetic pulses to stimulate the brain, aiming to reduce migraine pain. It is for people with frequent or chronic migraines who have not found relief from at least three preventive medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have frequent or chronic migraines, meaning more than 8 migraine days per month for at least 3 months, and no more than 26 headache days out of 28.
- You have tried at least three preventive migraine medications that did not work, caused side effects, or were not suitable for you.
- Your current pain medications have been stable for at least a month and will not change during the study.
- You do not have any metal implants or devices in your head or chest that could be affected by magnetic fields, and you have no history of seizures or epilepsy.
- You are not pregnant or breastfeeding, and you are not participating in another drug trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a non-drug treatment called repetitive transcranial magnetic stimulation (rTMS) that uses magnetic pulses to gently stimulate the brain. It aims to reduce migraine frequency by personalizing the treatment to each person's brain. If you have frequent migraines, this could offer a new option without daily pills.
This study tests whether repetitive transcranial magnetic stimulation (rTMS), guided by magnetoencephalography (MEG), can help people with frequent migraines or tension-type headaches. If you have headaches 15 or more days per month, this treatment might reduce your pain.
This study uses a safe, non-invasive technique called transcranial magnetic stimulation (TMS) to measure brain activity in people with migraine compared to healthy volunteers. It aims to understand how the brain's electrical signals differ in migraine, which could lead to better treatments.
This trial tests whether a noninvasive brain stimulation technique (rTMS) can help people with long-term nerve pain who also have depression. It aims to see if this treatment can reduce pain and improve mood.
This trial tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation, can reduce chronic nerve pain caused by cancer or its treatment. It may help patients who have not found relief from standard pain medications.
This trial tests whether a form of brain stimulation (rTMS) can reduce chronic nerve pain that has lasted more than a year and hasn’t improved with standard treatments. It may help people whose usual pain medicines are stable but still not working well.
Hear when a new rTMS Stimulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.